SenzaGen aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD® test platform, expansion of its test portfolio and evaluation of acquisition opportunities of profitable and growing companies with complementary offerings. SenzaGen has its headquarters and GLP-certified laboratory in Lund, Sweden and subsidiaries in the US and Italy.
View Top Employees from SenzaGenWebsite | http://www.senzagen.com |
Revenue | $6 million |
Employees | 21 (16 on RocketReach) |
Founded | 2010 |
Address | Scheelevägen 2, Lund, Skane 223 63, SE |
Phone | +46 46 275 62 00 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Biotechnology, Medical Testing & Clinical Laboratories, Laboratory Services (Healthcare), Safetytesting of chemical compounds, Healthcare, Science and Engineering, Skin sensitization, Chemical, Respiratory sensitization, Medical, Health Care |
Competitors | BioPorto Diagnostics A/S, Genomic Vision, HiberGene Diagnostics, Kypha, mdxhealth |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular SenzaGen employee's phone or email?
The SenzaGen annual revenue was $6 million in 2024.
Anna Hansson is the Vice President Business Development and Strategy of SenzaGen.
16 people are employed at SenzaGen.
SenzaGen is based in Lund, Skane.
The NAICS codes for SenzaGen are [541713, 54171, 54, 541, 5417].
The SIC codes for SenzaGen are [87, 873].